
-
2005
Company Description
Cerenis Therapeutics is a biotechnology company involved in the R&D of HDL therapies for cardiovascular and metabolic diseases.
Cerenis Therapeutics is a multinational biotechnology company dedicated to the discovery, development and commercialization of novel HDL therapies for the treatment of cardiovascular and metabolic diseases.
-
Manufacturer:
Science and Engineering -
Formed:
2005 -
Company Website:
-
Company E-mail:
-
Company Address:
265 rue de la Découverte - Bât. ALabègeFrance -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits